Join our workshop to learn how to turn your idea into a successful business. We'll show you how to create a strong business model, using real examples and expert advice from founders who've been there. Don't miss out on this opportunity to make your health tech innovation a reality.

In our workshop, we'll show you how to turn your health tech idea into a money-making venture. Learn to build a solid business model, find your market niche, and adapt to changes. Join us to explore how you can make your innovation a profitable and successful business.

What You Will Learn:

Develop a business model: Learn how to develop a potential business model for your health tech innovation by understanding market opportunities and competitive advantages.
Have a glimpse into the real-life examples of business cases: learn how ventures evolve over time to respond to changes in the market context.
Learn from the ones who have been there: gain insights from other founders who have commercialised their research or innovation, offering firsthand experience and answers your specific questions.

Who Should Attend

This masterclass is designed for entrepreneurs, researchers, and professionals in the health tech sector who are looking to transform your health tech idea into a profitable venture or seeking inspiration from industry leaders, this workshop equips you with the tools and insights necessary for success.

Meet the Experts:

Guests to be announced

**Lunch will be provided

Cicada Innovations is proud to be collaborating with the Westmead Health & Innovation District, Australia’s fastest-growing health and innovation precinct, for this commercialisation masterclass series. These masterclasses are to help bridge the gap between research and commercialisation.

Find out more about the Cicada HealthTech Hub

The Cicada HealthTech Hub is proudly supported by NSW Government and is part of the Westmead’s Health & Innovation District. The district includes 4 major hospitals, 4 world-leading medical research institutes, 2 university campuses and the largest research-intensive pathology service in NSW. By 2036, the number of full-time staff will increase to more than 50,000 and the number of students will expand to more than 10,000. Among the first projects for development is a viral vector advanced manufacturing facility to provide ground-breaking trial therapies for infections, cancer and genetic diseases.